Page last updated: 2024-08-23

vx and vx-770

vx has been researched along with vx-770 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Stower, H1
Heneghan, M; Murphy, J; Nevitt, SJ; Sinha, IP; Southern, KW1

Reviews

1 review(s) available for vx and vx-770

ArticleYear
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
    The Cochrane database of systematic reviews, 2023, 11-20, Volume: 11

    Topics: Adult; Aminophenols; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dyspnea; Humans; Mutation

2023

Other Studies

1 other study(ies) available for vx and vx-770

ArticleYear
Combination therapy.
    Nature medicine, 2019, Volume: 25, Issue:1

    Topics: Alleles; Aminophenols; Benzodioxoles; Cystic Fibrosis; Humans; Indoles; Organothiophosphorus Compounds; Quinolones

2019